In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples